| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/05/2004 | US20040024029 Thiazole and oxazole derivatives |
| 02/05/2004 | US20040024024 Inhibiting matrix metalloproteinase and aggrecanase activity; for treatment of strokes and neurodegenerative diseases |
| 02/05/2004 | US20040023998 2-(5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidyl)-N-(1-(2-(5-t -butyl-1,3,4-oxadiazolyl)carbonyl)-2-(R,S)-methylpropyl) acetamide; elastase inhibitors |
| 02/05/2004 | US20040023973 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. |
| 02/05/2004 | US20040023960 Mammalian metabolites of the compound 2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3- (4-fluoro) phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo) methylmorpholine which is a tachykinin receptor antagonist as antiemetics |
| 02/05/2004 | US20040023958 Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus. |
| 02/05/2004 | US20040023945 Cyclic amp-specific phosphodiesterase inhibitors |
| 02/05/2004 | US20040023808 Herbicidal 5-benzyloxymethyl-1,2-isoxazoline derivatives |
| 02/05/2004 | US20040023805 Substituted phenyluracils |
| 02/05/2004 | US20040023290 Novel therapeutic agents that modulate enzymatic processes |
| 02/05/2004 | DE10234875A1 4-Trifluormethylpyrazolyl substituierte Pyridine und Pyrimidine 4-substituted pyridines and pyrimidines Trifluormethylpyrazolyl |
| 02/05/2004 | DE10234288A1 Metallkomplexe als lichtabsorbierende Verbindungen in der Informationsschicht von optischen Datenträgern Metal complexes as light-absorbing compounds in the information layer of optical media |
| 02/05/2004 | CA2493156A1 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 02/05/2004 | CA2491733A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 02/04/2004 | EP1386922A2 Synthesis of epothilones, intermediates thereof, analogues and uses thereof |
| 02/04/2004 | EP1386912A1 Cyclic amidine derivative |
| 02/04/2004 | EP1385848A2 Phtalazinones derivatives useful as pde4/7 inhibitors |
| 02/04/2004 | EP1385845A1 N-aroyl cyclic amines |
| 02/04/2004 | EP1385844A1 Oxazolidinones containing a sulfonimid group as antibiotics |
| 02/04/2004 | EP1385841A1 Sulfonamides |
| 02/04/2004 | EP1385838A1 Piperazino-derivatives and their use as pde4 inhibitor |
| 02/04/2004 | EP1385836A2 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/04/2004 | EP1385834A1 Bicyclo[3,1,0]hexane containing oxazolidinone antibiotic and derivatives thereof |
| 02/04/2004 | EP1385506A2 Acylated piperidine derivates as melanocortin-4 receptor agonists |
| 02/04/2004 | EP0992503B1 Process for producing isooxazolidinedione compound |
| 02/04/2004 | CN1473161A Pyrazole compounds as protein kinase inhibitors |
| 02/04/2004 | CN1473155A Pyrimidine derivatives and herbicides containing the same |
| 02/04/2004 | CN1473154A Phthalazinone derivatives |
| 02/04/2004 | CN1473150A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 02/04/2004 | CN1473043A Method for treating allergies using substituted pyrazoles |
| 02/04/2004 | CN1137120C 5,11-Dihydrodibenz[b,e][1,4] oxazepine derivatives and medical composition containg the same |
| 02/04/2004 | CN1137118C Water soluble azoles as broad-spectrun antifungals |
| 02/03/2004 | US6686478 Thienylsulphonylamino(thio)carbonyl compounds |
| 02/03/2004 | US6686383 Treatment of diabetic nephropathy with a biphenyl-4-yl)alkyl-1h-benzimidazole compounds |
| 02/03/2004 | US6686382 N-(isoxazolyl)thienylsulfonamides, n-(isoxazolyl)furylsulfonamides, n-(isoxazolyl)pyrrolylsulfonamides and n-(isoxazolyl)phenylsulfonamides; inhibit endothelin |
| 02/03/2004 | US6686372 Selective β3 adrenergic agonists |
| 02/03/2004 | US6686363 Effective against multi-resistant bacteria |
| 02/03/2004 | US6686357 Benzimidazolo-piperidine compound |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686351 Compounds and methods for modulation of estrogen receptors |
| 02/03/2004 | US6685617 4-(((-1-carboxy-2-(4-((2,6-dichlorobenzoyl)amine)phenyl)ethyl) amino)carbonyl)-3-oxo-3-thiazolidinebutanoic acid, used as antagonists for cellular adhesion molecules, and administered as antiinflammatory agents |
| 01/29/2004 | WO2004009599A1 Five-membered heteroaromatic olefinic azacyclic compounds, pharmaceutical compositions containing them and their use as inhibitors of ncotinic cholinergic receptors |
| 01/29/2004 | WO2004009587A1 Oxazolidinone derivatives as antibacterial agents |
| 01/29/2004 | WO2004009586A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| 01/29/2004 | WO2004009551A1 Process for producing 2-substituted pyridine derivative |
| 01/29/2004 | WO2004008859A1 Fused-benzene derivatives of thiouracil, herbicidal and desiccant compositions contaning them |
| 01/29/2004 | WO2003072572A8 Beta3-adrenergic receptor agonists |
| 01/29/2004 | WO2003066035A3 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/29/2004 | WO2003053366A3 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 01/29/2004 | WO2003000180A3 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/29/2004 | WO2002066473A8 8’4-’3-(5-fluoro-1h-indol-3yl) propyl!-1-piperazynyl!-2-methyl-2h-1,4-benzoxazin -3 (4h)- one methanesulfonate with high affinity for the dopamine d 2 receptor and the serotonin reuptake site |
| 01/29/2004 | US20040019113 Phosphate transport inhibitors |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019090 2-(4-(2-(2-biphenyl-yl-5-methyl-thiazol-4-yl)-alkoxy)-phenoxy) -2-methyl-propionic acid derivatives; antidiabetic agents |
| 01/29/2004 | US20040019089 Multidrug resistant cell inhibitors; anticancer agents |
| 01/29/2004 | US20040019088 Use of Epothilones in the treatment of brain diseases associated with proliferative processes |
| 01/29/2004 | US20040019059 Drugs such as N-(4-benzoylphenyl)-4,5-dihydro-3-(3-pyridinyl)-5-isoxazolecarboxamide, used as antiinflammatory or antiarthritic agents |
| 01/29/2004 | US20040019050 Selective NPY (Y5) antagonists (triazines) |
| 01/29/2004 | US20040019046 Phenylacetamido-pyrazole derivatives and their use as antitumor agents |
| 01/29/2004 | US20040019041 Method for the production of imidazo-(1,2-C)(2,3)-benzodiazepines and intermediates in the production thereof |
| 01/29/2004 | US20040019039 Substituted piperazines and diazepanes |
| 01/29/2004 | US20040019038 Compounds useful as anti-inflammatory agents |
| 01/29/2004 | US20040019016 Polycyclic compounds containing a central trivalent atom to which is attached either direct or indirectly via a linker a two or three ring system and a ring system contining sulphamate group as substituent; steroid sulfatase inhibitor |
| 01/29/2004 | US20040019015 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss |
| 01/29/2004 | US20040018941 Applying to plants; synergistic mixture |
| 01/29/2004 | US20040018598 Chemical intermediate for discodermolide, epothilone |
| 01/28/2004 | EP1384722A1 Process for the production of 2-(5-methyl-4-oxazolyl)acetates |
| 01/28/2004 | EP1384715A1 Novel imidazolidinedione derivatives and use thereof as drugs |
| 01/28/2004 | EP1384713A1 4-amino-azepan-3-one derivatives as protease inhibitors |
| 01/28/2004 | EP1383760A1 Biarylcarboxamide compounds as apolipoprotein b inhibitors |
| 01/28/2004 | EP1383759A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 01/28/2004 | EP1383754A1 Process for making taxane derivatives |
| 01/28/2004 | EP1383749A1 Arylsulfonamides as antiviral agents |
| 01/28/2004 | EP1383748A2 Novel compounds and compositions as cathepsin inhibitors |
| 01/28/2004 | EP1383744A1 Novel piperidine derivatives as modulators of chemokine receptor |
| 01/28/2004 | EP1383501A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/28/2004 | EP1143946B1 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 01/28/2004 | EP1082322B1 Oxazolidinone derivatives as antibiotic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/28/2004 | CN1471524A Novel farnesyl protein transferase inhibitors as antitumor |
| 01/28/2004 | CN1471520A Aminoalkyl benzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 01/28/2004 | CN1471517A OXAZOLYL-arylpropionic acid derivatives and their sue as PPAR agonists |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/28/2004 | CN1471394A Tripeptidyl peptidase inhibitors |
| 01/28/2004 | CN1136203C Benzoxazine and penzothiazine derivatives and their use in pharmaceuticals |
| 01/28/2004 | CN1136198C Novel benzyl pyrimidines |
| 01/28/2004 | CN1136192C Aryl and hetaryl-sulfonamide derivatives, their preparation and use as endo thelin antagonists |
| 01/28/2004 | CN1136191C Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 01/28/2004 | CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them |
| 01/27/2004 | US6683213 Chemical intermediates for pyridinedicarboxamide herbicides |
| 01/27/2004 | US6683192 Substituted benzo(b)thien compounds useful for modulating proliferation or differentiation of a cell, agonizes hedgehog mediated signal trasnduction with an ed50 of 1mm or less |
| 01/27/2004 | US6683103 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/27/2004 | US6683091 Heterocyclic sulfanamides; alzheimer's disease; preventing deposition of amyloid protein |
| 01/27/2004 | US6683079 Reverse transcriptase inhibitors |
| 01/27/2004 | US6683077 2-Amino-benzoxazinones for the treatment of viral infections |
| 01/27/2004 | US6683028 Cyclic guanidine derivatives and their use as pesticides |
| 01/22/2004 | WO2004007489A2 Antibacterial substituted cyanomethyl (ene) piperidinophenyl oxazolidinones, process or their preparation, and pharmaceutical compositions containing them |
| 01/22/2004 | WO2004007488A2 Antimicrobial oxazolidinones, process of their preparation, and pharmaceutical compositions containing them |
| 01/22/2004 | WO2004007481A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 01/22/2004 | WO2004007470A1 Novel anthracene derivatives and the use thereof as a medicament |